e-learning
resources
ERJ
Supplements
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interstitial lung disease induced by exogenous agents: factors governing susceptibility
Nemery B., Bast A., Behr J., Borm P.J.A., Bourke S.J., Camus Ph., De Vuyst P., Jansen H.M., Kinnula V.L., Lison D., Pelkonen O., Saltini C.
Source:
Eur Respir J 2001; 18: 30S-42S
Journal Issue:
July 2001 - Suppl. 32
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nemery B., Bast A., Behr J., Borm P.J.A., Bourke S.J., Camus Ph., De Vuyst P., Jansen H.M., Kinnula V.L., Lison D., Pelkonen O., Saltini C.. Interstitial lung disease induced by exogenous agents: factors governing susceptibility. Eur Respir J 2001; 18: 30S-42S
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Hypersensitivity pneumonitis: current concepts
Source: Eur Respir J 2001; 18: 81S-92S
Year: 2001
COPD: inflammatory mechanisms and systemic consequences
Source: Eur Respir Mon 2013; 59: 13-27
Year: 2013
Development of new treatments for complex chronic comorbidities
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008
Implications for disease and therapy
Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD
Year: 2005
Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure
Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021
Year: 2021
Oxidative stress as common mechanism of inflammation in chronic lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 344s
Year: 2005
Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms
Source: Eur Respir J 2007; 29: 793-803
Year: 2007
Strain dependence of lung tissue mechanics in a murine model of chronic asthma
Source: Annual Congress 2006 - Respiratory mechanics
Year: 2006
Expression of MIC-A in bronchial epithelium associates with cigarette smoking: a sign of induced autoimmune mechanisms?
Source: Annual Congress 2005 - Lung structure: current concepts
Year: 2005
Interplay between bacterial infections, hypoxia and the development of chronic lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Carbonyl stress and enhanced macrophage function
Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD
Year: 2005
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin
Source: Eur Respir J 2001; 18: 17S-29S
Year: 2001
The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005
Pathogenesis of occupational asthma, including genetic factors
Source: Annual Congress 2005 - Occupational asthma
Year: 2005
Rare interstitial lung diseases of environmental origin
Source: Eur Respir Mon 2011; 54: 301-316
Year: 2011
Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006
Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept